anbefaler CPMP ændring af de markedsføringstilladelser, for hvilke produktresuméet er gengivet i bilag III for Pravachol og de tilknyttede navne (se bilag I).
the CPMP has recommended the amendment of the Marketing Authorisations for which the Summary of Product Characteristics is set out in Annex III of the CPMP Opinion for Pravachol and associated names (see Annex I).